About the conference
The World Vaccine Congress Australia 2008 offers a unique opportunity to get a complete and up to date picture on developments within the local and global vaccine industry.
WorldVaccine Congress 2008 is the largest, most established and most dynamic vaccine industry conference in the world, with annual events held inWashington, Lyon and Singapore. For ten years the conference series has brought together the best international speakers from government and
regulatory bodies, vaccine manufacturers, biotech, academia and non-government financing organisations.
In 2008 the WorldVaccine Congress comes to Australia for the first time.We have brought the global leaders to Australia to discuss both the commercial and public health issues faced by the vaccines industry today.
Delivered to you by 30+ senior executives this critical event aims to identify opportunities to maximise vaccine innovation and accessibility. WorldVaccine Congress Australia will examine the effects of the latest immunisation policy updates, analyse the industry's most successful development and financing models and explore the latest clinical updates in global priority vaccines,
delivery systems and adjuvant therapies.
The international vaccine market is experiencing an unprecedented period of growth due to increased investment in innovation and recent groundbreaking discoveries. This growth has left the industry asking questions like how do all of the players need to work together to increase global access to vaccines, what is the future of vaccine R&D in light of technology advances and how do we maintain the current level of innovation. Have these questions and more answered at WorldVaccine Congress Australia
For more details
Look at the conference programme
Find out about the masterclass
Conference topics:
The World Vaccine Congress Australia conference programme will focus on both the commercial and scientific aspects of the vaccines industry such as:
-
Global business models – partnering with biotech, private venture capitalists, NGOs and overseas players
-
Vaccines and investment – funding strategies for developing countries, orphan vaccines and sustainable immunisation financing
-
Designing the best immunisation strategy for Australia and streamlining regulatory approval
-
Innovations and developments in delivery systems, adjuvants and manufacturing processes
-
The next generation of vaccines- viral vectors, therapeutic, cancer and DNA vaccines
|
The "Terrapinn experience"
The earlier you book the more you save
|
Attendee profile
This event will attract representatives from the big vaccine, pharmaceutical and biotech sectors as well as the Government and public health sectors. Contract Manufacturing Organisations and Contract Research Organisations in the services sector will also attend reflecting the value of the event as a place to raise your profile, generate leads and achieve your commercial goals.
| Attendees by industry: |
Attendees by job function: |
Big Vaccine
Contract Services
Consultants
Legal
Government
Public Health
Financiers
Bioprocess technology vendors
Manufacturing technology
Engineering providers
Academic Institutions
By Geography:
- Australia
- India
- Singapore
- New Zealand
|
- Chief Scientific Officer
- Head of Vaccines
- Head of Vaccines Development
- Head of R&D
- Head of Vaccines Manufacturing
- Head of Strategic Manufacturing
- Head of Planning & Scheduling
- Head of Licensing and IP
- Head of Patent/Legal
- Head of Operations
- Head of Regulation
- Head of Clinical Trials
- Head of Marketing
- Head of Business Development
- Head of Bioprocess & Technology Development
- Principle Scientist of Biotech
- Head of Project Finance
- Head of Purchasing and Procurement
- Head of Environment, Health and Safety
|
|
